Harvard Bioscience Inc. (NASDAQ:HBIO) saw unusually-high trading volume on Thursday . Approximately 119,286 shares traded hands during trading, an increase of 42% from the previous session’s volume of 84,016 shares.The stock last traded at $2.54 and had previously closed at $2.53.

Separately, Zacks Investment Research raised Harvard Bioscience from a “sell” rating to a “hold” rating in a research note on Tuesday, July 12th.

The stock’s market capitalization is $89.90 million. The stock’s 50 day moving average is $2.84 and its 200 day moving average is $2.99.

Harvard Bioscience (NASDAQ:HBIO) last issued its quarterly earnings results on Thursday, July 28th. The company reported $0.03 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.03. The firm had revenue of $26.10 million for the quarter, compared to analyst estimates of $26.60 million. Equities research analysts anticipate that Harvard Bioscience Inc. will post $0.16 earnings per share for the current year.

Harvard Bioscience, Inc is a developer, manufacturer and marketer of a range of specialized products, apparatus and scientific instruments. The Company’s products are used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories across the world.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.